Basic Information
Biotecnol is a privately held biopharmaceutical company working in the field of immuno-oncology. Biotecnol develops highly specific antibody-based immunotherapies that activate and direct the defense mechanisms of a patient’s own immune system, such as their own killer T-cells (T-lymphocytes that kill cancer cells), to fight various types of cancer where standard-of-care treatments offer little or no benefit.